{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:06:09Z","timestamp":1789610769775,"version":"build-2803163510"},"reference-count":244,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-024-02125-z","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T05:02:44Z","timestamp":1724130164000},"page":"1042-1062","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["MicroRNAs Modulating Neuroinflammation in Parkinson's disease"],"prefix":"10.1007","volume":"48","author":[{"given":"Mohamed J.","family":"Saadh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faris Anad","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamika","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Ahmed","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafil Adnan Hussein","family":"Al Zuhairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Ghildiyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan","family":"hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Alsaikhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayan","family":"Khalilollah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Akhavan-Sigari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"issue":"8","key":"2125_CR1","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1096\/fj.08-125153","volume":"23","author":"J Waak","year":"2009","unstructured":"Waak, J., S.S. Weber, A. Waldenmaier, K. G\u00f6rner, M. Alunni-Fabbroni, H. Schell, et al. 2009. Regulation of astrocyte inflammatory responses by the Parkinson\u2019s disease-associated gene DJ\u20131. The FASEB Journal. 23 (8): 2478\u20132489.","journal-title":"The FASEB Journal."},{"key":"2125_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10654-011-9581-6","volume":"26","author":"K Wirdefeldt","year":"2011","unstructured":"Wirdefeldt, K., H.-O. Adami, P. Cole, D. Trichopoulos, and J. Mandel. 2011. Epidemiology and etiology of Parkinson\u2019s disease: A review of the evidence. European Journal of Epidemiology. 26: 1\u201358.","journal-title":"European Journal of Epidemiology."},{"issue":"1","key":"2125_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","volume":"991","author":"S Fahn","year":"2003","unstructured":"Fahn, S. 2003. Description of Parkinson\u2019s disease as a clinical syndrome. Annals of the New York Academy of Sciences. 991 (1): 1\u201314.","journal-title":"Annals of the New York Academy of Sciences."},{"issue":"8","key":"2125_CR4","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnen\/62.8.812","volume":"62","author":"F Mori","year":"2003","unstructured":"Mori, F., Y.-S. Piao, S. Hayashi, H. Fujiwara, M. Hasegawa, M. Yoshimoto, et al. 2003. \u03b1-Synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy. Journal of Neuropathology & Experimental Neurology. 62 (8): 812\u2013819.","journal-title":"Journal of Neuropathology & Experimental Neurology."},{"issue":"12","key":"2125_CR5","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.3390\/biomedicines10123241","volume":"10","author":"A Surguchov","year":"2022","unstructured":"Surguchov, A., and A. Surguchev. 2022. Synucleins: New Data on Misfolding, Aggregation and Role in Diseases. Biomedicines 10 (12): 3241.","journal-title":"Biomedicines"},{"issue":"1","key":"2125_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang, Q., Y. Liu, and J. Zhou. 2015. Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Translational Neurodegeneration. 4 (1): 19.","journal-title":"Translational Neurodegeneration."},{"issue":"2","key":"2125_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","volume":"76","author":"ML Block","year":"2005","unstructured":"Block, M.L., and J.-S. Hong. 2005. Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism. Progress in Neurobiology. 76 (2): 77\u201398.","journal-title":"Progress in Neurobiology."},{"issue":"1","key":"2125_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/bmb\/ldl018","volume":"79","author":"FD Dick","year":"2006","unstructured":"Dick, F.D. 2006. Parkinson\u2019s disease and pesticide exposures. British Medical Bulletin 79 (1): 219\u2013231.","journal-title":"British Medical Bulletin"},{"issue":"7","key":"2125_CR9","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/cells12071012","volume":"12","author":"S Isik","year":"2023","unstructured":"Isik, S., B. Yeman Kiyak, R. Akbayir, R. Seyhali, and T. Arpaci. 2023. Microglia Mediated Neuroinflammation in Parkinson\u2019s Disease. Cells 12 (7): 1012.","journal-title":"Cells"},{"key":"2125_CR10","doi-asserted-by":"publisher","first-page":"111826","DOI":"10.1016\/j.mad.2023.111826","volume":"213","author":"SN Uppala","year":"2023","unstructured":"Uppala, S.N., K.P. Tryphena, P. Naren, S. Srivastava, S.B. Singh, and D.K. Khatri. 2023. Involvement of miRNA on epigenetics landscape of Parkinson\u2019s disease: From pathogenesis to therapeutics. Mechanisms of Ageing and Development. 213: 111826.","journal-title":"Mechanisms of Ageing and Development."},{"issue":"1","key":"2125_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s13721-024-00445-6","volume":"13","author":"G Singh","year":"2024","unstructured":"Singh, G., and D.K. Khatri. 2024. MicroRNA-gene regulatory network of TLR signaling in neuroinflammation-induced Parkinson\u2019s disease: A bioinformatics approach. Network Modeling Analysis in Health Informatics and Bioinformatics. 13 (1): 7.","journal-title":"Network Modeling Analysis in Health Informatics and Bioinformatics."},{"issue":"8","key":"2125_CR12","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1021\/cr300362f","volume":"113","author":"H Dong","year":"2013","unstructured":"Dong, H., J. Lei, L. Ding, Y. Wen, H. Ju, and X. Zhang. 2013. MicroRNA: Function, detection, and bioanalysis. Chemical Reviews. 113 (8): 6207\u20136233.","journal-title":"Chemical Reviews."},{"issue":"11","key":"2125_CR13","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.tips.2019.09.007","volume":"40","author":"Q Lu","year":"2019","unstructured":"Lu, Q., R. Wu, M. Zhao, A. Garcia-Gomez, and E. Ballestar. 2019. miRNAs as therapeutic targets in inflammatory disease. Trends in Pharmacological Sciences. 40 (11): 853\u2013865.","journal-title":"Trends in Pharmacological Sciences."},{"key":"2125_CR14","doi-asserted-by":"publisher","first-page":"104692","DOI":"10.1016\/j.micpath.2020.104692","volume":"150","author":"BM Hussen","year":"2021","unstructured":"Hussen, B.M., G. Ahmadi, H. Marzban, M.E.F. Azar, S. Sorayyayi, R. Karampour, et al. 2021. The role of HPV gene expression and selected cellular MiRNAs in lung cancer development. Microbial Pathogenesis. 150: 104692.","journal-title":"Microbial Pathogenesis."},{"key":"2125_CR15","first-page":"13","volume-title":"Exosomal MicroRNA Profiling","author":"N Rahimian","year":"2022","unstructured":"Rahimian, N., J.S. Nahand, M.R. Hamblin, and H. Mirzaei. 2022. Exosomal MicroRNA Profiling, 13\u201347. MicroRNA Profiling: Methods and Protocols."},{"key":"2125_CR16","doi-asserted-by":"publisher","unstructured":"Sadri Nahand, J., Salmaninejad, A. Mollazadeh, S., Tamehri Zadeh, S., S. Rezaee, M. Sheida A.H. et al.\u00a02022.  Virus, exosome, and MicroRNA: new insights into autophagy.\u00a0Advances in Experimental Medicine and Biology 1401:97\u2013162. https:\/\/doi.org\/10.1007\/5584_2022_715.\u00a0","DOI":"10.1007\/5584_2022_715"},{"key":"2125_CR17","doi-asserted-by":"publisher","unstructured":"Mirzaei, H., Rahimian, N., Mirzaei, H. R, Nahand, J. S., Hamblin. M. R.\u00a02022. Exosomes and microRNAs in biomedical science.\u00a0Morgan & Claypool Publishers. https:\/\/doi.org\/10.1007\/978-3-031-79177-2.","DOI":"10.1007\/978-3-031-79177-2"},{"key":"2125_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00441-007-0530-3","volume":"331","author":"S Hatfield","year":"2008","unstructured":"Hatfield, S., and H. Ruohola-Baker. 2008. microRNA and stem cell function. Cell Tissue Research 331: 57\u201366.","journal-title":"Cell Tissue Research"},{"issue":"3","key":"2125_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/07853890701771823","volume":"40","author":"DJ Guarnieri","year":"2008","unstructured":"Guarnieri, D.J., and R.J. DiLeone. 2008. MicroRNAs: A new class of gene regulators. Annals of Medicine 40 (3): 197\u2013208.","journal-title":"Annals of Medicine"},{"issue":"3","key":"2125_CR20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.neuron.2012.07.005","volume":"75","author":"E McNeill","year":"2012","unstructured":"McNeill, E., and D. Van Vactor. 2012. MicroRNAs shape the neuronal landscape. Neuron 75 (3): 363\u2013379.","journal-title":"Neuron"},{"key":"2125_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fncel.2013.00265","volume":"7","author":"S Maciotta","year":"2013","unstructured":"Maciotta, S., M. Meregalli, and Y. Torrente. 2013. The involvement of microRNAs in neurodegenerative diseases. Frontiers in Cellular Neuroscience 7: 265.","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"1","key":"2125_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-016-0094-3","volume":"11","author":"Y Zhou","year":"2016","unstructured":"Zhou, Y., M. Lu, R.H. Du, C. Qiao, C.Y. Jiang, K.Z. Zhang, et al. 2016. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson\u2019s disease. Molecular Neurodegeneration 11 (1): 28.","journal-title":"Molecular Neurodegeneration"},{"issue":"1","key":"2125_CR23","doi-asserted-by":"publisher","first-page":"672","DOI":"10.18632\/aging.102649","volume":"12","author":"LJ Cai","year":"2020","unstructured":"Cai, L.J., L. Tu, T. Li, X.L. Yang, Y.P. Ren, R. Gu, et al. 2020. Up-regulation of microRNA-375 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson\u2019s disease by inhibiting SP1. Aging 12 (1): 672\u2013689.","journal-title":"Aging"},{"key":"2125_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neuroscience.2018.07.019","volume":"388","author":"B Cao","year":"2018","unstructured":"Cao, B., T. Wang, Q. Qu, T. Kang, and Q. Yang. 2018. Long noncoding RNA SNHG1 promotes neuroinflammation in Parkinson\u2019s disease via regulating miR-7\/NLRP3 pathway. Neuroscience 388: 118\u2013127.","journal-title":"Neuroscience"},{"issue":"6357","key":"2125_CR25","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla, L.F., P. Song, J.R. Mazzulli, E. Zampese, Y.C. Wong, S. Jeon, et al. 2017. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science (New York, NY). 357 (6357): 1255\u20131261.","journal-title":"Science (New York, NY)."},{"issue":"S17","key":"2125_CR26","doi-asserted-by":"publisher","first-page":"S335","DOI":"10.1002\/mds.21675","volume":"22","author":"CW Olanow","year":"2007","unstructured":"Olanow, C.W. 2007. The pathogenesis of cell death in Parkinson\u2019s disease\u20132007. Movement disorders: Official Journal of the Movement Disorder Society. 22 (S17): S335\u2013S342.","journal-title":"Movement disorders: Official Journal of the Movement Disorder Society."},{"key":"2125_CR27","doi-asserted-by":"crossref","unstructured":"Jia C, Cheng C, Li T, Chen X, Yang Y, Liu X, et al.\u00a02021. \u03b1-Synuclein Up-regulates monoamine oxidase a expression and activity via trans-acting transcription factor 1. Frontiers in Aging Neuroscience. 13:653379.","DOI":"10.3389\/fnagi.2021.653379"},{"issue":"2","key":"2125_CR28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1365-2567.2009.03225.x","volume":"129","author":"S Amor","year":"2010","unstructured":"Amor, S., F. Puentes, D. Baker, and P. Van Der Valk. 2010. Inflammation in neurodegenerative diseases. Immunology 129 (2): 154\u2013169.","journal-title":"Immunology"},{"issue":"1","key":"2125_CR29","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard, V., B. Combadi\u00e8re, A. Prigent, Y. Laouar, A. Perrin, V. Beray-Berthat, et al. 2009. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. The Journal of Clinical Investigation 119 (1): 182\u2013192.","journal-title":"The Journal of Clinical Investigation"},{"issue":"11","key":"2125_CR30","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey, M.G., R.L. Wallings, M.C. Houser, M.K. Herrick, C.E. Keating, and V. Joers. 2022. Inflammation and immune dysfunction in Parkinson disease. Nature Reviews Immunology. 22 (11): 657\u2013673.","journal-title":"Nature Reviews Immunology."},{"issue":"1","key":"2125_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2007.07.004","volume":"208","author":"MG Tansey","year":"2007","unstructured":"Tansey, M.G., M.K. McCoy, and T.C. Frank-Cannon. 2007. Neuroinflammatory mechanisms in Parkinson\u2019s disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention. Experimental Neurology. 208 (1): 1\u201325.","journal-title":"Experimental Neurology."},{"key":"2125_CR32","doi-asserted-by":"crossref","unstructured":"Stojkovska, I., B.M. Wagner, and B.E. Morrison. 2015. Parkinson\u2019s disease and enhanced inflammatory response. Experimental Biology and Medicine (Maywood, NJ). 240 (11): 1387\u20131395.","DOI":"10.1177\/1535370215576313"},{"key":"2125_CR33","doi-asserted-by":"crossref","unstructured":"Tufekci KU, Meuwissen R, Genc S, Genc K.\u00a02012. Chapter four - inflammation in parkinson's disease. In Donev R, ed. Advances in Protein Chemistry and Structural Biology.\u00a0 Academic Press. 88:69\u2013132.","DOI":"10.1016\/B978-0-12-398314-5.00004-0"},{"issue":"Pt 5","key":"2125_CR34","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1042\/BST0351127","volume":"35","author":"ML Block","year":"2007","unstructured":"Block, M.L., and J.S. Hong. 2007. Chronic microglial activation and progressive dopaminergic neurotoxicity. Biochemical Society Transactions. 35 (Pt 5): 1127\u20131132.","journal-title":"Biochemical Society Transactions."},{"issue":"10","key":"2125_CR35","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1177\/1352458514533230","volume":"20","author":"J Correale","year":"2014","unstructured":"Correale, J. 2014. The role of microglial activation in disease progression. Multiple Sclerosis Journal. 20 (10): 1288\u20131295.","journal-title":"Multiple Sclerosis Journal."},{"issue":"3","key":"2125_CR36","first-page":"141","volume":"62","author":"I Miyazaki","year":"2008","unstructured":"Miyazaki, I., and M. Asanuma. 2008. Dopaminergic neuron-specific oxidative stress caused by dopamine itself. Acta Medica Okayama. 62 (3): 141\u2013150.","journal-title":"Acta Medica Okayama."},{"key":"2125_CR37","doi-asserted-by":"publisher","first-page":"9163040","DOI":"10.1155\/2018\/9163040","volume":"2018","author":"M Weng","year":"2018","unstructured":"Weng, M., X. Xie, C. Liu, K.L. Lim, C.W. Zhang, and L. Li. 2018. The Sources of Reactive Oxygen Species and Its Possible Role in the Pathogenesis of Parkinson\u2019s Disease. Parkinson\u2019s Disease. 2018: 9163040.","journal-title":"Parkinson's Disease."},{"key":"2125_CR38","doi-asserted-by":"crossref","unstructured":"Weng M, Xie X, Liu C, Lim K-L, Zhang C-w, Li L.\u00a02018. The sources of reactive oxygen species and its possible role in the pathogenesis of parkinson\u2019s disease. Parkinson\u2019s Disease. (1): 9163040.","DOI":"10.1155\/2018\/9163040"},{"key":"2125_CR39","doi-asserted-by":"publisher","first-page":"480739","DOI":"10.1155\/2013\/480739","volume":"2013","author":"G Ramesh","year":"2013","unstructured":"Ramesh, G., A.G. MacLean, and M.T. Philipp. 2013. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators of Inflammation. 2013: 480739.","journal-title":"Mediators of Inflammation."},{"issue":"8","key":"2125_CR40","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s11910-022-01207-5","volume":"22","author":"G Arena","year":"2022","unstructured":"Arena, G., K. Sharma, G. Agyeah, R. Kr\u00fcger, A. Gr\u00fcnewald, and J.C. Fitzgerald. 2022. Neurodegeneration and Neuroinflammation in Parkinson\u2019s Disease: A Self-Sustained Loop. Current Neurology and Neuroscience Reports. 22 (8): 427\u2013440.","journal-title":"Current Neurology and Neuroscience Reports."},{"issue":"3","key":"2125_CR41","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","volume":"37","author":"MG Tansey","year":"2010","unstructured":"Tansey, M.G., and M.S. Goldberg. 2010. Neuroinflammation in Parkinson\u2019s disease: Its role in neuronal death and implications for therapeutic intervention. Neurobiology of Disease 37 (3): 510\u2013518.","journal-title":"Neurobiology of Disease"},{"issue":"9","key":"2125_CR42","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.3390\/ijms22094676","volume":"22","author":"K Badanjak","year":"2021","unstructured":"Badanjak, K., S. Fixemer, S. Smaji\u0107, A. Skupin, and A. Gr\u00fcnewald. 2021. The Contribution of Microglia to Neuroinflammation in Parkinson\u2019s Disease. International Journal of Molecular Sciences 22 (9): 4676.","journal-title":"International Journal of Molecular Sciences"},{"issue":"6301","key":"2125_CR43","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff, R.M. 2016. How neuroinflammation contributes to neurodegeneration. Science (New York, NY). 353 (6301): 777\u2013783.","journal-title":"Science (New York, NY)."},{"issue":"30","key":"2125_CR44","doi-asserted-by":"publisher","first-page":"7687","DOI":"10.1523\/JNEUROSCI.0143-07.2008","volume":"28","author":"HM Gao","year":"2008","unstructured":"Gao, H.M., P.T. Kotzbauer, K. Uryu, S. Leight, J.Q. Trojanowski, and V.M. Lee. 2008. Neuroinflammation and oxidation\/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. The Journal of neuroscience\u202f: The official journal of the Society for Neuroscience. 28 (30): 7687\u20137698.","journal-title":"The Journal of neuroscience : The official journal of the Society for Neuroscience."},{"issue":"12","key":"2125_CR45","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1523\/JNEUROSCI.5321-06.2007","volume":"27","author":"MP Mount","year":"2007","unstructured":"Mount, M.P., A. Lira, D. Grimes, P.D. Smith, S. Faucher, R. Slack, et al. 2007. Involvement of interferon-\u03b3 in microglial-mediated loss of dopaminergic neurons. Journal of Neuroscience. 27 (12): 3328\u20133337.","journal-title":"Journal of Neuroscience."},{"issue":"1","key":"2125_CR46","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1038\/ncomms4633","volume":"5","author":"C Cebri\u00e1n","year":"2014","unstructured":"Cebri\u00e1n, C., F.A. Zucca, P. Mauri, J.A. Steinbeck, L. Studer, C.R. Scherzer, et al. 2014. MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration. Nature communications. 5 (1): 3633.","journal-title":"Nature communications."},{"issue":"9","key":"2125_CR47","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/glia.23028","volume":"64","author":"BS Main","year":"2016","unstructured":"Main, B.S., M. Zhang, K.M. Brody, S. Ayton, T. Frugier, D. Steer, et al. 2016. Type-1 interferons contribute to the neuroinflammatory response and disease progression of the MPTP mouse model of Parkinson\u2019s disease. Glia 64 (9): 1590\u20131604.","journal-title":"Glia"},{"key":"2125_CR48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.toxlet.2016.11.002","volume":"265","author":"QS Zhang","year":"2017","unstructured":"Zhang, Q.S., Y. Heng, Y.H. Yuan, and N.H. Chen. 2017. Pathological \u03b1-synuclein exacerbates the progression of Parkinson\u2019s disease through microglial activation. Toxicology Letters 265: 30\u201337.","journal-title":"Toxicology Letters"},{"key":"2125_CR49","doi-asserted-by":"crossref","unstructured":"Gundersen V.\u00a02021. Parkinson\u2019s Disease: can targeting inflammation be an effective neuroprotective strategy? Frontiers in neuroscience. 14:580311.","DOI":"10.3389\/fnins.2020.580311"},{"issue":"6","key":"2125_CR50","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang, W., T. Wang, Z. Pei, D.S. Miller, X. Wu, M.L. Block, et al. 2005. Aggregated alpha-synuclein activates microglia: A process leading to disease progression in Parkinson\u2019s disease. FASEB Journal\u202f: Official Publication of the Federation of American Societies for Experimental Biology 19 (6): 533\u2013542.","journal-title":"FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology"},{"issue":"11","key":"2125_CR51","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.neurobiolaging.2007.04.006","volume":"29","author":"X Su","year":"2008","unstructured":"Su, X., K.A. Maguire-Zeiss, R. Giuliano, L. Prifti, K. Venkatesh, and H.J. Federoff. 2008. Synuclein activates microglia in a model of Parkinson\u2019s disease. Neurobiology of Aging. 29 (11): 1690\u20131701.","journal-title":"Neurobiology of Aging."},{"issue":"3","key":"2125_CR52","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/j.1471-4159.2009.06189.x","volume":"110","author":"L Marinova-Mutafchieva","year":"2009","unstructured":"Marinova-Mutafchieva, L., M. Sadeghian, L. Broom, J.B. Davis, A.D. Medhurst, and D.T. Dexter. 2009. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: A time course study in a 6-hydroxydopamine model of Parkinson\u2019s disease. Journal of Neurochemistry. 110 (3): 966\u2013975.","journal-title":"Journal of Neurochemistry."},{"issue":"1","key":"2125_CR53","doi-asserted-by":"publisher","first-page":"e8784","DOI":"10.1371\/journal.pone.0008784","volume":"5","author":"V Sanchez-Guajardo","year":"2010","unstructured":"Sanchez-Guajardo, V., F. Febbraro, D. Kirik, and M. Romero-Ramos. 2010. Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson\u2019s disease. PLoS ONE 5 (1): e8784.","journal-title":"PLoS ONE"},{"issue":"2","key":"2125_CR54","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1600-0404.1998.tb01736.x","volume":"98","author":"T M\u00fcller","year":"1998","unstructured":"M\u00fcller, T., D. Blum-Degen, H. Przuntek, and W. Kuhn. 1998. Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson\u2019s disease. Acta Neurologica Scandinavica. 98 (2): 142\u2013144.","journal-title":"Acta Neurologica Scandinavica."},{"key":"2125_CR55","doi-asserted-by":"crossref","unstructured":"Chiareli,\u00a0Raphaela Almeida, Gustavo Almeida Carvalho,\u00a0Bruno Lemes Marques,\u00a0Lennia\u00a0On\u00e9sia\u00a0Mota,\u00a0On\u00e9sia Cristina Oliveira-Lima,\u00a0Rodrigo Mello Gomes,\u00a0Alexander Birbrair\u00a0et al.\u00a02021. \"The role of astrocytes in the neurorepair process.\" Frontiers in Cell and Developmental Biology. 9:665795.","DOI":"10.3389\/fcell.2021.665795"},{"issue":"6","key":"2125_CR56","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/cns.13123","volume":"25","author":"B Zhou","year":"2019","unstructured":"Zhou, B., Y.X. Zuo, and R.T. Jiang. 2019. Astrocyte morphology: Diversity, plasticity, and role in neurological diseases. CNS Neuroscience & Therapeutics 25 (6): 665\u2013673.","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"1","key":"2125_CR57","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40478-023-01526-9","volume":"11","author":"JM Lawrence","year":"2023","unstructured":"Lawrence, J.M., K. Schardien, B. Wigdahl, and M.R. Nonnemacher. 2023. Roles of neuropathology-associated reactive astrocytes: A systematic review. Acta Neuropathologica Communications. 11 (1): 42.","journal-title":"Acta Neuropathologica Communications."},{"issue":"7","key":"2125_CR58","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/cells9071687","volume":"9","author":"M Pajares","year":"2020","unstructured":"Pajares, M., I.A. Rojo, G. Manda, L. Bosc\u00e1, and A. Cuadrado. 2020. Inflammation in Parkinson\u2019s Disease: Mechanisms and Therapeutic Implications. Cells 9 (7): 1687.","journal-title":"Cells"},{"issue":"3","key":"2125_CR59","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","volume":"114","author":"H Braak","year":"2007","unstructured":"Braak, H., M. Sastre, and K. Del Tredici. 2007. Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson\u2019s disease. Acta Neuropathologica. 114 (3): 231\u2013241.","journal-title":"Acta Neuropathologica."},{"issue":"2","key":"2125_CR60","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.expneurol.2005.10.034","volume":"197","author":"J Miklossy","year":"2006","unstructured":"Miklossy, J., D.D. Doudet, C. Schwab, S. Yu, E.G. McGeer, and P.L. McGeer. 2006. Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys. Experimental Neurology. 197 (2): 275\u2013283.","journal-title":"Experimental Neurology."},{"issue":"4","key":"2125_CR61","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.neures.2008.09.001","volume":"62","author":"J Henning","year":"2008","unstructured":"Henning, J., U. Strauss, A. Wree, J. Gimsa, A. Rolfs, R. Benecke, et al. 2008. Differential astroglial activation in 6-hydroxydopamine models of Parkinson\u2019s disease. Neuroscience Research. 62 (4): 246\u2013253.","journal-title":"Neuroscience Research."},{"key":"2125_CR62","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1756-6606-3-12","volume":"3","author":"XL Gu","year":"2010","unstructured":"Gu, X.L., C.X. Long, L. Sun, C. Xie, X. Lin, and H. Cai. 2010. Astrocytic expression of Parkinson\u2019s disease-related A53T alpha-synuclein causes neurodegeneration in mice. Molecular Brain 3: 12.","journal-title":"Molecular Brain"},{"issue":"14","key":"2125_CR63","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1093\/hmg\/dds143","volume":"21","author":"I Lastres-Becker","year":"2012","unstructured":"Lastres-Becker, I., A. Ulusoy, N.G. Innamorato, G. Sahin, A. R\u00e1bano, D. Kirik, et al. 2012. \u03b1-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson\u2019s disease. Human Molecular Genetics. 21 (14): 3173\u20133192.","journal-title":"Human Molecular Genetics."},{"issue":"7638","key":"2125_CR64","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S.A., K.A. Guttenplan, L.E. Clarke, F.C. Bennett, C.J. Bohlen, L. Schirmer, et al. 2017. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541 (7638): 481\u2013487.","journal-title":"Nature"},{"issue":"1","key":"2125_CR65","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12987-022-00367-3","volume":"19","author":"F Khodadadei","year":"2022","unstructured":"Khodadadei, F., R. Arshad, D.M. Morales, J. Gluski, N.I. Marupudi, J.P. McAllister, et al. 2022. The effect of A1 and A2 reactive astrocyte expression on hydrocephalus shunt failure. Fluids and Barriers of the CNS. 19 (1): 78.","journal-title":"Fluids and Barriers of the CNS."},{"issue":"18","key":"2125_CR66","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","volume":"32","author":"JL Zamanian","year":"2012","unstructured":"Zamanian, J.L., L. Xu, L.C. Foo, N. Nouri, L. Zhou, R.G. Giffard, et al. 2012. Genomic analysis of reactive astrogliosis. The Journal of Neuroscience\u202f: The Official Journal of the Society for Neuroscience 32 (18): 6391\u20136410.","journal-title":"The Journal of Neuroscience : The Official Journal of the Society for Neuroscience"},{"issue":"6","key":"2125_CR67","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","volume":"46","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S.A., and B.A. Barres. 2017. Reactive Astrocytes: Production, Function, and Therapeutic Potential. Immunity 46 (6): 957\u2013967.","journal-title":"Immunity"},{"key":"2125_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-019-1524-2","volume":"16","author":"T Li","year":"2019","unstructured":"Li, T., X. Chen, C. Zhang, Y. Zhang, and W. Yao. 2019. An update on reactive astrocytes in chronic pain. Journal of Neuroinflammation 16: 1\u201313.","journal-title":"Journal of Neuroinflammation"},{"issue":"10","key":"2125_CR69","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1002\/glia.23467","volume":"66","author":"M Neal","year":"2018","unstructured":"Neal, M., J. Luo, D.S. Harischandra, R. Gordon, S. Sarkar, H. Jin, et al. 2018. Prokineticin-2 promotes chemotaxis and alternative A2 reactivity of astrocytes. Glia 66 (10): 2137\u20132157.","journal-title":"Glia"},{"issue":"12","key":"2125_CR70","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","volume":"285","author":"HJ Lee","year":"2010","unstructured":"Lee, H.J., J.E. Suk, C. Patrick, E.J. Bae, J.H. Cho, S. Rho, et al. 2010. Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. The Journal of Biological Chemistry. 285 (12): 9262\u20139272.","journal-title":"The Journal of Biological Chemistry."},{"issue":"2","key":"2125_CR71","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell, B.R., J.P. Friedmann Angeli, H. Bayir, A.I. Bush, M. Conrad, S.J. Dixon, et al. 2017. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell 171 (2): 273\u2013285.","journal-title":"Cell"},{"issue":"4","key":"2125_CR72","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/jnc.13024","volume":"133","author":"PR Angelova","year":"2015","unstructured":"Angelova, P.R., M.H. Horrocks, D. Klenerman, S. Gandhi, A.Y. Abramov, and M.S. Shchepinov. 2015. Lipid peroxidation is essential for \u03b1-synuclein-induced cell death. Journal of Neurochemistry 133 (4): 582\u2013589.","journal-title":"Journal of Neurochemistry"},{"key":"2125_CR73","doi-asserted-by":"crossref","unstructured":"Bantle, Collin, M., Hirst,\u00a0W. D., Weihofen A, Shlevkov, E.\u00a02021. Mitochondrial dysfunction in astrocytes: A role in parkinson\u2019s disease? Frontiers in Cell and Developmental Biology. 8:608026.","DOI":"10.3389\/fcell.2020.608026"},{"issue":"6","key":"2125_CR74","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","volume":"40","author":"HDE Booth","year":"2017","unstructured":"Booth, H.D.E., W.D. Hirst, and R. Wade-Martins. 2017. The Role of Astrocyte Dysfunction in Parkinson\u2019s Disease Pathogenesis. Trends in Neurosciences. 40 (6): 358\u2013370.","journal-title":"Trends in Neurosciences."},{"issue":"5","key":"2125_CR75","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee, R.C., R.L. Feinbaum, and V.J. Ambros. 1993. The C elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 (5): 843\u201354.","journal-title":"Cell"},{"issue":"10","key":"2125_CR76","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3390\/ijms17101712","volume":"17","author":"C Catalanotto","year":"2016","unstructured":"Catalanotto, C., and C. Cogoni. 2016. Zardo GJIjoms MicroRNA in control of gene expression: An overview of nuclear functions. International Journal of Molecular Sciences 17 (10): 1712.","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"2125_CR77","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DPJ Bartel","year":"2009","unstructured":"Bartel, D.P.J. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136 (2): 215\u201333.","journal-title":"Cell"},{"issue":"20","key":"2125_CR78","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1111\/febs.14482","volume":"285","author":"C Nejad","year":"2018","unstructured":"Nejad, C., and H.J. Stunden. 2018. Gantier MPJTFj A guide to miRNAs in inflammation and innate immune responses. The FEBS Journal 285 (20): 3695\u20133716.","journal-title":"The FEBS Journal"},{"issue":"12","key":"2125_CR79","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1261\/rna.2248605","volume":"11","author":"RSJR Pillai","year":"2005","unstructured":"Pillai, R.S.J.R. 2005. MicroRNA function: multiple mechanisms for a tiny RNA? Rna 11 (12): 1753\u201361.","journal-title":"Rna"},{"issue":"7209","key":"2125_CR80","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature07228","volume":"455","author":"M Selbach","year":"2008","unstructured":"Selbach, M., B. Schwanh\u00e4usser, N. Thierfelder, Z. Fang, R. Khanin, and N. Rajewsky. 2008. Widespread changes in protein synthesis induced by microRNAs. Nature 455 (7209): 58\u201363.","journal-title":"Nature"},{"issue":"1","key":"2125_CR81","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/msb.2011.100","volume":"8","author":"S Uhlmann","year":"2012","unstructured":"Uhlmann, S., H. Mannsperger, J.D. Zhang, E.\u00c1. Horvat, C. Schmidt, M. K\u00fcblbeck, et al. 2012. Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer. Molecular Systems Biology 8 (1): 570.","journal-title":"Molecular Systems Biology"},{"issue":"1","key":"2125_CR82","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.molcel.2007.06.017","volume":"27","author":"A Grimson","year":"2007","unstructured":"Grimson, A., K.K.H. Farh, W.K. Johnston, P. Garrett-Engele, L.P. Lim, and D.P. Bartel. 2007. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Molecular Cell 27 (1): 91\u2013105.","journal-title":"Molecular Cell"},{"issue":"7","key":"2125_CR83","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1093\/nar\/gkm133","volume":"35","author":"P S\u00e6trom","year":"2007","unstructured":"S\u00e6trom, P., B.S. Heale, O. Sn\u00f8ve Jr., L. Aagaard, J. Alluin, and J.J. Rossi. 2007. Distance constraints between microRNA target sites dictate efficacy and cooperativity. Nucleic Acids Research. 35 (7): 2333\u20132342.","journal-title":"Nucleic Acids Research."},{"issue":"1","key":"2125_CR84","first-page":"1","volume":"17","author":"H Mirzaei","year":"2022","unstructured":"Mirzaei, H., N. Rahimian, H.R. Mirzaei, and J.S. Nahand. 2022. Hamblin MRJSLoBE. Exosomes and MicroRNAs in Biomedical Science 17 (1): 1\u2013175.","journal-title":"Exosomes and MicroRNAs in Biomedical Science"},{"key":"2125_CR85","first-page":"487","volume":"24","author":"JS Nahand","year":"2021","unstructured":"Nahand, J.S., L. Shojaie, S.A. Akhlagh, M.S. Ebrahimi, H.R. Mirzaei, H.B. Baghi, et al. 2021. Cell Death Pathways and Viruses: Role of MicroRNAs 24: 487\u2013511.","journal-title":"Cell Death Pathways and Viruses: Role of MicroRNAs"},{"issue":"3","key":"2125_CR86","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/leu.2011.356","volume":"26","author":"J Contreras","year":"2012","unstructured":"Contreras, J., and D. Rao. 2012. MicroRNAs in inflammation and immune responses. Leukemia 26 (3): 404\u2013413.","journal-title":"Leukemia"},{"issue":"3","key":"2125_CR87","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/leu.2011.356","volume":"26","author":"J Contreras","year":"2012","unstructured":"Contreras, J., and D.S. Rao. 2012. MicroRNAs in inflammation and immune responses. Leukemia 26 (3): 404\u2013413.","journal-title":"Leukemia"},{"issue":"1","key":"2125_CR88","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nsmb1041","volume":"13","author":"W Yang","year":"2006","unstructured":"Yang, W., T.P. Chendrimada, Q. Wang, M. Higuchi, P.H. Seeburg, R. Shiekhattar, et al. 2006. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nature Structural & Molecular Biology 13 (1): 13\u201321.","journal-title":"Nature Structural & Molecular Biology"},{"issue":"6","key":"2125_CR89","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.molimm.2008.11.012","volume":"46","author":"JL Wiesen","year":"2009","unstructured":"Wiesen, J.L., and T.B. Tomasi. 2009. Dicer is regulated by cellular stresses and interferons. Molecular Immunology. 46 (6): 1222\u20131228.","journal-title":"Molecular Immunology."},{"issue":"7254","key":"2125_CR90","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature08199","volume":"460","author":"HI Suzuki","year":"2009","unstructured":"Suzuki, H.I., K. Yamagata, K. Sugimoto, T. Iwamoto, S. Kato, and K. Miyazono. 2009. Modulation of microRNA processing by p53. Nature 460 (7254): 529\u2013533.","journal-title":"Nature"},{"issue":"5872","key":"2125_CR91","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.1154040","volume":"320","author":"SR Viswanathan","year":"2008","unstructured":"Viswanathan, S.R., G.Q. Daley, and R.I. Gregory. 2008. Selective blockade of microRNA processing by Lin28. Science 320 (5872): 97\u2013100.","journal-title":"Science"},{"issue":"2","key":"2125_CR92","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1161\/ATVBAHA.112.300068","volume":"33","author":"G Liu","year":"2013","unstructured":"Liu, G., and E. Abraham. 2013. MicroRNAs in immune response and macrophage polarization. Arteriosclerosis, Thrombosis, and Vascular Biology 33 (2): 170\u2013177.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"2125_CR93","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-immunol-020711-075013","volume":"30","author":"RM O'Connell","year":"2012","unstructured":"O\u2019Connell, R.M., D.S. Rao, and D. Baltimore. 2012. microRNA regulation of inflammatory responses. Annual Review of Immunology 30: 295\u2013312.","journal-title":"Annual Review of Immunology"},{"key":"2125_CR94","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3389\/fimmu.2018.01377","volume":"9","author":"A Tahamtan","year":"2018","unstructured":"Tahamtan, A., M. Teymoori-Rad, B. Nakstad, and V. Salimi. 2018. Anti-inflammatory microRNAs and their potential for inflammatory diseases treatment. Frontiers in Immunology 9: 1377.","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"2125_CR95","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/ni.1828","volume":"11","author":"FJ Sheedy","year":"2010","unstructured":"Sheedy, F.J., E. Palsson-McDermott, E.J. Hennessy, C. Martin, J.J. O\u2019leary, Q. Ruan, et al. 2010. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nature Immunology 11 (2): 141\u20137.","journal-title":"Nature Immunology"},{"issue":"1","key":"2125_CR96","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000455981","volume":"41","author":"Q Lin","year":"2017","unstructured":"Lin, Q., Y. Geng, M. Zhao, S. Lin, Q. Zhu, and Z. Tian. 2017. MiR-21 regulates TNF-\u03b1-induced CD40 expression via the SIRT1-NF-\u03baB pathway in renal inner medullary collecting duct cells. Cellular Physiology and Biochemistry. 41 (1): 124\u2013136.","journal-title":"Cellular Physiology and Biochemistry."},{"issue":"1","key":"2125_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-511X-13-27","volume":"13","author":"J Feng","year":"2014","unstructured":"Feng, J., A. Li, J. Deng, Y. Yang, L. Dang, Y. Ye, et al. 2014. miR-21 attenuates lipopolysaccharide-induced lipid accumulation and inflammatory response: Potential role in cerebrovascular disease. Lipids in Health and Disease 13 (1): 1\u20139.","journal-title":"Lipids in Health and Disease"},{"issue":"6","key":"2125_CR98","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.4049\/jimmunol.1101235","volume":"187","author":"TX Lu","year":"2011","unstructured":"Lu, T.X., J. Hartner, E.-J. Lim, V. Fabry, M.K. Mingler, E.T. Cole, et al. 2011. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12\/IFN-\u03b3 pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. The Journal of Immunology. 187 (6): 3362\u20133373.","journal-title":"The Journal of Immunology."},{"issue":"7","key":"2125_CR99","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","volume":"129","author":"P Landgraf","year":"2007","unstructured":"Landgraf, P., M. Rusu, R. Sheridan, A. Sewer, N. Iovino, A. Aravin, et al. 2007. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129 (7): 1401\u20131414.","journal-title":"Cell"},{"issue":"5824","key":"2125_CR100","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1126\/science.1139253","volume":"316","author":"A Rodriguez","year":"2007","unstructured":"Rodriguez, A., E. Vigorito, S. Clare, M.V. Warren, P. Couttet, D.R. Soond, et al. 2007. Requirement of bic\/microRNA-155 for normal immune function. Science 316 (5824): 608\u2013611.","journal-title":"Science"},{"issue":"6","key":"2125_CR101","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.immuni.2007.11.010","volume":"27","author":"K Calame","year":"2007","unstructured":"Calame, K. 2007. MicroRNA-155 function in B Cells. Immunity 27 (6): 825\u2013827.","journal-title":"Immunity"},{"issue":"6","key":"2125_CR102","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1089\/jir.2018.0155","volume":"39","author":"G Mahesh","year":"2019","unstructured":"Mahesh, G., and R. Biswas. 2019. MicroRNA-155: A Master Regulator of Inflammation. Journal of Interferon & Cytokine Research\u202f: The Official Journal of the International Society for Interferon and Cytokine Research 39 (6): 321\u2013330.","journal-title":"Journal of Interferon & Cytokine Research : The Official Journal of the International Society for Interferon and Cytokine Research"},{"issue":"39","key":"2125_CR103","doi-asserted-by":"publisher","first-page":"65397","DOI":"10.18632\/oncotarget.18541","volume":"8","author":"Q Zhang","year":"2017","unstructured":"Zhang, Q., J. Su, Z. Wang, H. Qi, Z. Ge, Z. Li, et al. 2017. MicroRNA-149* suppresses hepatic inflammatory response through antagonizing STAT3 signaling pathway. Oncotarget 8 (39): 65397.","journal-title":"Oncotarget"},{"issue":"5","key":"2125_CR104","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/jcb.24734","volume":"115","author":"G Xu","year":"2014","unstructured":"Xu, G., Z. Zhang, Y. Xing, J. Wei, Z. Ge, X. Liu, et al. 2014. Microrna-149 negatively regulates tlr-triggered inflammatory response in macrophages by targeting myd88. Journal of Cellular Biochemistry 115 (5): 919\u2013927.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"1","key":"2125_CR105","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bbrc.2013.11.092","volume":"443","author":"D Palmieri","year":"2014","unstructured":"Palmieri, D., S. Capponi, A. Geroldi, M. Mura, P. Mandich, and D. Palombo. 2014. TNF\u03b1 induces the expression of genes associated with endothelial dysfunction through p38MAPK-mediated down-regulation of miR-149. Biochemical and Biophysical Research Communications 443 (1): 246\u2013251.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"9","key":"2125_CR106","doi-asserted-by":"publisher","first-page":"4956","DOI":"10.3390\/ijms22094956","volume":"22","author":"M Rasheed","year":"2021","unstructured":"Rasheed, M., J. Liang, C. Wang, Y. Deng, and Z. Chen. 2021. Epigenetic regulation of neuroinflammation in Parkinson\u2019s disease. International Journal of Molecular Sciences 22 (9): 4956.","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"2125_CR107","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s12264-023-01023-y","volume":"39","author":"Q-Q Han","year":"2023","unstructured":"Han, Q.-Q., and W. Le. 2023. NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson\u2019s Disease. Neuroscience Bulletin 39 (5): 832\u2013844.","journal-title":"Neuroscience Bulletin"},{"issue":"7","key":"2125_CR108","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.3233\/JPD-223290","volume":"12","author":"LTN Nguyen","year":"2022","unstructured":"Nguyen, L.T.N., H.D. Nguyen, Y.J. Kim, T.T. Nguyen, T.T. Lai, Y.K. Lee, et al. 2022. Role of NLRP3 Inflammasome in Parkinson\u2019s Disease and Therapeutic Considerations. Journal of Parkinson\u2019s Disease 12 (7): 2117\u20132133.","journal-title":"Journal of Parkinson's Disease"},{"issue":"10","key":"2125_CR109","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","volume":"19","author":"MT Heneka","year":"2018","unstructured":"Heneka, M.T., R.M. McManus, and E. Latz. 2018. Inflammasome signalling in brain function and neurodegenerative disease. Nature Reviews Neuroscience 19 (10): 610\u2013621.","journal-title":"Nature Reviews Neuroscience"},{"issue":"6","key":"2125_CR110","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/bpa.12196","volume":"24","author":"GJ Liu","year":"2014","unstructured":"Liu, G.J., R.J. Middleton, C.R. Hatty, W.W. Kam, R. Chan, T. Pham, et al. 2014. The 18 kDa translocator protein, microglia and neuroinflammation. Brain Pathology (Zurich, Switzerland) 24 (6): 631\u2013653.","journal-title":"Brain Pathology (Zurich, Switzerland)"},{"issue":"4","key":"2125_CR111","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.3390\/ijms22041636","volume":"22","author":"A G\u00f3mez Morillas","year":"2021","unstructured":"G\u00f3mez Morillas, A., V.C. Besson, and D. Lerouet. 2021. Microglia and neuroinflammation: What place for P2RY12? International Journal of Molecular Sciences. 22 (4): 1636.","journal-title":"International Journal of Molecular Sciences."},{"issue":"1","key":"2125_CR112","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-1-14","volume":"1","author":"WJ Streit","year":"2004","unstructured":"Streit, W.J., R.E. Mrak, and W.S. Griffin. 2004. Microglia and neuroinflammation: A pathological perspective. Journal of Neuroinflammation 1 (1): 14.","journal-title":"Journal of Neuroinflammation"},{"key":"2125_CR113","doi-asserted-by":"publisher","first-page":"655819","DOI":"10.3389\/fcell.2021.655819","volume":"9","author":"L Yao","year":"2021","unstructured":"Yao, L., J. Wu, S. Koc, and G. Lu. 2021. Genetic Imaging of Neuroinflammation in Parkinson\u2019s Disease: Recent Advancements. Frontiers in Cell and Developmental Biology 9: 655819.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"2","key":"2125_CR114","doi-asserted-by":"publisher","first-page":"787","DOI":"10.4049\/jimmunol.0901363","volume":"183","author":"FG Bauernfeind","year":"2009","unstructured":"Bauernfeind, F.G., G. Horvath, A. Stutz, E.S. Alnemri, K. MacDonald, D. Speert, et al. 2009. Cutting edge: NF-\u03baB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. The Journal of Immunology. 183 (2): 787\u2013791.","journal-title":"The Journal of Immunology."},{"key":"2125_CR115","doi-asserted-by":"publisher","first-page":"101915","DOI":"10.1016\/j.arr.2023.101915","volume":"87","author":"S Rajan","year":"2023","unstructured":"Rajan, S., K.P. Tryphena, S. Khan, L. Vora, S. Srivastava, S.B. Singh, et al. 2023. Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson\u2019s disease. Ageing Research Reviews. 87: 101915.","journal-title":"Ageing Research Reviews."},{"key":"2125_CR116","doi-asserted-by":"publisher","first-page":"115496","DOI":"10.1016\/j.bcp.2023.115496","volume":"210","author":"S Samim Khan","year":"2023","unstructured":"Samim Khan, S., S. Janrao, S. Srivastava, S. Bala Singh, L. Vora, and K.D. Kumar. 2023. GSK-3\u03b2: An exuberating neuroinflammatory mediator in Parkinson\u2019s disease. Biochemical Pharmacology. 210: 115496.","journal-title":"Biochemical Pharmacology."},{"issue":"23","key":"2125_CR117","doi-asserted-by":"publisher","first-page":"8067","DOI":"10.1073\/pnas.0709684105","volume":"105","author":"A Piccini","year":"2008","unstructured":"Piccini, A., S. Carta, S. Tassi, D. Lasigli\u00e9, G. Fossati, and A. Rubartelli. 2008. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1\u03b2 and IL-18 secretion in an autocrine way. Proceedings of the National Academy of Sciences. 105 (23): 8067\u20138072.","journal-title":"Proceedings of the National Academy of Sciences."},{"issue":"5876","key":"2125_CR118","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1126\/science.1156995","volume":"320","author":"C Dostert","year":"2008","unstructured":"Dostert, C., V. P\u00e9trilli, R. Van Bruggen, C. Steele, and B.T. Mossman. 2008. Tschopp Jr. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science (New York, NY) 320 (5876): 674\u20137.","journal-title":"Science (New York, NY)"},{"issue":"1","key":"2125_CR119","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/0022034510378683","volume":"90","author":"D Bayarsaihan","year":"2011","unstructured":"Bayarsaihan, D. 2011. Epigenetic mechanisms in inflammation. Journal of Dental Research 90 (1): 9\u201317.","journal-title":"Journal of Dental Research"},{"key":"2125_CR120","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pbiomolbio.2019.05.004","volume":"150","author":"P Zamani","year":"2020","unstructured":"Zamani, P., R.K. Oskuee, S.L. Atkin, J.G. Navashenaq, and A. Sahebkar. 2020. MicroRNAs as important regulators of the NLRP3 inflammasome. Progress in Biophysics and Molecular Biology 150: 50\u201361.","journal-title":"Progress in Biophysics and Molecular Biology"},{"key":"2125_CR121","doi-asserted-by":"publisher","first-page":"118918","DOI":"10.1016\/j.lfs.2020.118918","volume":"267","author":"Q Ge","year":"2021","unstructured":"Ge, Q., X. Chen, Y. Zhao, H. Mu, and J. Zhang. 2021. Modulatory mechanisms of NLRP3: Potential roles in inflammasome activation. Life Sciences 267: 118918.","journal-title":"Life Sciences"},{"key":"2125_CR122","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.imlet.2021.03.004","volume":"233","author":"KU Tufekci","year":"2021","unstructured":"Tufekci, K.U., I. Ercan, K.B. Isci, M. Olcum, B. Tastan, C.P. Gonul, et al. 2021. Sulforaphane inhibits NLRP3 inflammasome activation in microglia through Nrf2-mediated miRNA alteration. Immunology Letters 233: 20\u201330.","journal-title":"Immunology Letters"},{"issue":"2","key":"2125_CR123","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s13577-017-0187-5","volume":"31","author":"D Li","year":"2018","unstructured":"Li, D., H. Yang, J. Ma, S. Luo, S. Chen, and Q. Gu. 2018. MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson\u2019s disease by targeting Nlrp3. Human Cell 31 (2): 106\u2013115.","journal-title":"Human Cell"},{"issue":"4","key":"2125_CR124","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.immuni.2007.04.005","volume":"26","author":"CA Dinarello","year":"2007","unstructured":"Dinarello, C.A. 2007. A signal for the caspase-1 inflammasome free of TLR. Immunity 26 (4): 383\u2013385.","journal-title":"Immunity"},{"issue":"6","key":"2125_CR125","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder, K. 2010. Tschopp J. The inflammasomes. Cell 140 (6): 821\u2013832.","journal-title":"Cell"},{"key":"2125_CR126","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.1016\/S1353-8020(11)70064-5","volume":"18","author":"S Phani","year":"2012","unstructured":"Phani, S., J.D. Loike, and S. Przedborski. 2012. Neurodegeneration and Inflammation in Parkinson\u2019s disease. Parkinsonism & Related Disorders. 18: S207\u2013S209.","journal-title":"Parkinsonism & Related Disorders."},{"issue":"12","key":"2125_CR127","doi-asserted-by":"publisher","first-page":"23379","DOI":"10.1002\/jcp.28907","volume":"234","author":"Q Sun","year":"2019","unstructured":"Sun, Q., S. Wang, J. Chen, H. Cai, W. Huang, Y. Zhang, et al. 2019. MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson\u2019s disease mouse model. Journal of Cellular Physiology 234 (12): 23379\u201323387.","journal-title":"Journal of Cellular Physiology"},{"key":"2125_CR128","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neuroscience.2018.07.019","volume":"388","author":"B Cao","year":"2018","unstructured":"Cao, B., T. Wang, Q. Qu, T. Kang, and Q. Yang. 2018. Long Noncoding RNA SNHG1 Promotes Neuroinflammation in Parkinson\u2019s Disease via Regulating miR-7\/NLRP3 Pathway. Neuroscience 388: 118\u2013127.","journal-title":"Neuroscience"},{"key":"2125_CR129","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-981-13-9913-8_13","volume":"1175","author":"MS Ho","year":"2019","unstructured":"Ho, M.S. 2019. Microglia in Parkinson\u2019s Disease. Advances in Experimental Medicine and Biology 1175: 335\u2013353.","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"4","key":"2125_CR130","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.bbrc.2019.08.140","volume":"519","author":"J Zhang","year":"2019","unstructured":"Zhang, J., D. Zhou, Z. Zhang, X. Qu, K. Bao, G. Lu, et al. 2019. miR-let-7a suppresses \u03b1-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson\u2019s disease. Biochemical and Biophysical Research Communications 519 (4): 740\u2013746.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"2125_CR131","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00109-013-1090-5","volume":"92","author":"P Przanowski","year":"2014","unstructured":"Przanowski, P., M. Dabrowski, A. Ellert-Miklaszewska, M. Kloss, J. Mieczkowski, B. Kaza, et al. 2014. The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia. Journal of Molecular Medicine 92: 239\u2013254.","journal-title":"Journal of Molecular Medicine"},{"key":"2125_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-10-143","volume":"10","author":"S Tanaka","year":"2013","unstructured":"Tanaka, S., A. Ishii, H. Ohtaki, S. Shioda, T. Yoshida, and S. Numazawa. 2013. Activation of microglia induces symptoms of Parkinson\u2019s disease in wild-type, but not in IL-1 knockout mice. Journal of Neuroinflammation 10: 1\u201311.","journal-title":"Journal of Neuroinflammation"},{"issue":"2","key":"2125_CR133","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.1080\/21655979.2022.2033409","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang, J., Y. Yang, C. Zhou, R. Zhu, X. Xiao, B. Zhou, et al. 2022. LncRNA miR-17-92a-1 cluster host gene (MIR17HG) promotes neuronal damage and microglial activation by targeting the microRNA-153-3p\/alpha-synuclein axis in Parkinson\u2019s disease. Bioengineered 13 (2): 4493\u20134516.","journal-title":"Bioengineered"},{"issue":"10","key":"2125_CR134","doi-asserted-by":"publisher","first-page":"e22867","DOI":"10.1002\/jbt.22867","volume":"35","author":"H Zhang","year":"2021","unstructured":"Zhang, H., Z. Wang, K. Hu, and H. Liu. 2021. Downregulation of long noncoding RNA SNHG7 protects against inflammation and apoptosis in Parkinson\u2019s disease model by targeting the miR-425-5p\/TRAF5\/NF-\u03baB axis. Journal of Biochemical and Molecular Toxicology 35 (10): e22867.","journal-title":"Journal of Biochemical and Molecular Toxicology"},{"issue":"6","key":"2125_CR135","first-page":"5153","volume":"19","author":"Y Ren","year":"2019","unstructured":"Ren, Y., H. Li, W. Xie, N. Wei, and M. Liu. 2019. MicroRNA-195 triggers neuroinflammation in Parkinson\u2019s disease in a Rho-associated kinase 1-dependent manner. Molecular Medicine Reports 19 (6): 5153\u20135161.","journal-title":"Molecular Medicine Reports"},{"issue":"8","key":"2125_CR136","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/glia.23153","volume":"65","author":"Q He","year":"2017","unstructured":"He, Q., Q. Wang, C. Yuan, and Y. Wang. 2017. Downregulation of miR-7116-5p in microglia by MPP+ sensitizes TNF-\u03b1 production to induce dopaminergic neuron damage. Glia 65 (8): 1251\u20131263.","journal-title":"Glia"},{"issue":"6","key":"2125_CR137","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/cpr.12292","volume":"49","author":"Y Li","year":"2016","unstructured":"Li, Y., A. Guo, Y. Feng, Y. Zhang, J. Wang, L. Jing, et al. 2016. Sp1 transcription factor promotes TMEPAI gene expression and contributes to cell proliferation. Cell Proliferation. 49 (6): 710\u2013719.","journal-title":"Cell Proliferation."},{"issue":"53","key":"2125_CR138","doi-asserted-by":"publisher","first-page":"7096","DOI":"10.1038\/sj.onc.1209696","volume":"25","author":"E Deniaud","year":"2006","unstructured":"Deniaud, E., J. Baguet, A.-L. Mathieu, J. Marvel, and Y. Leverrier. 2006. Overexpression of Sp1 transcription factor induces apoptosis. Oncogene 25 (53): 7096\u20137105.","journal-title":"Oncogene"},{"key":"2125_CR139","doi-asserted-by":"publisher","first-page":"6010362","DOI":"10.1155\/2021\/6010362","volume":"2021","author":"Y Cao","year":"2021","unstructured":"Cao, Y., X. Tan, Q. Lu, K. Huang, X. Tang, and Z. He. 2021. miR-590-3 and SP1 Promote Neuronal Apoptosis in Patients with Alzheimer\u2019s Disease via AMPK Signaling Pathway. Contrast Media & Molecular Imaging 2021: 6010362.","journal-title":"Contrast Media & Molecular Imaging"},{"key":"2125_CR140","doi-asserted-by":"crossref","unstructured":"Ma,\u00a0Ya-Min, Zhao L.\u00a02023. Mechanism and therapeutic prospect of miRNAs in neurodegenerative diseases. Behavioural Neurology.\u00a0 (1): 8537296.","DOI":"10.1155\/2023\/8537296"},{"issue":"10","key":"2125_CR141","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/jnr.24266","volume":"96","author":"L Yao","year":"2018","unstructured":"Yao, L., X. Dai, Y. Sun, Y. Wang, Q. Yang, X. Chen, et al. 2018. Inhibition of transcription factor SP1 produces neuroprotective effects through decreasing MAO B activity in MPTP\/MPP+ Parkinson\u2019s disease models. Journal of Neuroscience Research 96 (10): 1663\u20131676.","journal-title":"Journal of Neuroscience Research"},{"issue":"1","key":"2125_CR142","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3233\/ADR-210311","volume":"5","author":"YJ Tan","year":"2021","unstructured":"Tan, Y.J., B.Y.X. Wong, R. Vaidyanathan, S. Sreejith, S.Y. Chia, N. Kandiah, et al. 2021. Altered Cerebrospinal Fluid Exosomal microRNA Levels in Young-Onset Alzheimer\u2019s Disease and Frontotemporal Dementia. Journal of Alzheimer\u2019s Disease Reports 5 (1): 805\u2013813.","journal-title":"Journal of Alzheimer's Disease Reports"},{"issue":"3","key":"2125_CR143","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/1440-1681.13212","volume":"47","author":"R Wang","year":"2020","unstructured":"Wang, R., Y. Yang, H. Wang, Y. He, and C. Li. 2020. MiR-29c protects against inflammation and apoptosis in Parkinson\u2019s disease model in vivo and in vitro by targeting SP1. Clinical and Experimental Pharmacology and Physiology 47 (3): 372\u2013382.","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"2125_CR144","doi-asserted-by":"publisher","first-page":"147814","DOI":"10.1016\/j.brainres.2022.147814","volume":"1782","author":"X Sun","year":"2022","unstructured":"Sun, X., C. Zhang, H. Tao, S. Yao, and X. Wu. 2022. LINC00943 acts as miR-338-3p sponge to promote MPP+-induced SK-N-SH cell injury by directly targeting SP1 in Parkinson\u2019s disease. Brain Research 1782: 147814.","journal-title":"Brain Research"},{"key":"2125_CR145","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.wneu.2021.08.147","volume":"156","author":"S Wang","year":"2021","unstructured":"Wang, S., Q. Wen, B. Xiong, L. Zhang, X. Yu, and X. Ouyang. 2021. Long Noncoding RNA NEAT1 Knockdown Ameliorates 1-Methyl-4-Phenylpyridine\u2013Induced Cell Injury Through MicroRNA-519a-3p\/SP1 Axis in Parkinson Disease. World Neurosurgery 156: e93\u2013e103.","journal-title":"World Neurosurgery"},{"issue":"3","key":"2125_CR146","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.cell.2007.02.048","volume":"129","author":"T Fukao","year":"2007","unstructured":"Fukao, T., Y. Fukuda, K. Kiga, J. Sharif, K. Hino, Y. Enomoto, et al. 2007. An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 129 (3): 617\u2013631.","journal-title":"Cell"},{"issue":"5","key":"2125_CR147","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.cell.2005.09.023","volume":"123","author":"F Fazi","year":"2005","unstructured":"Fazi, F., A. Rosa, A. Fatica, V. Gelmetti, M.L. De Marchis, C. Nervi, et al. 2005. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C\/EBP\u03b1 regulates human granulopoiesis. Cell 123 (5): 819\u2013831.","journal-title":"Cell"},{"issue":"17","key":"2125_CR148","first-page":"3875","volume":"119","author":"RM O'Connell","year":"2012","unstructured":"O\u2019Connell, R.M. 2012. MicroRNAs function on a new level. Blood, The Journal of the American Society of Hematology 119 (17): 3875\u20133876.","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"15","key":"2125_CR149","doi-asserted-by":"publisher","first-page":"10318","DOI":"10.1074\/jbc.M113.526749","volume":"289","author":"D Date","year":"2014","unstructured":"Date, D., R. Das, G. Narla, D.I. Simon, M.K. Jain, and G.H. Mahabeleshwar. 2014. Kruppel-like transcription factor 6 regulates inflammatory macrophage polarization. Journal of Biological Chemistry 289 (15): 10318\u201310329.","journal-title":"Journal of Biological Chemistry"},{"issue":"10","key":"2125_CR150","doi-asserted-by":"publisher","first-page":"10902","DOI":"10.1096\/fj.201900867RR","volume":"33","author":"G-D Kim","year":"2019","unstructured":"Kim, G.-D., H.P. Ng, N. Patel, and G.H. Mahabeleshwar. 2019. Kruppel-like factor 6 and miR-223 signaling axis regulates macrophage-mediated inflammation. The FASEB Journal 33 (10): 10902.","journal-title":"The FASEB Journal"},{"issue":"17","key":"2125_CR151","first-page":"4034","volume":"119","author":"G Zardo","year":"2012","unstructured":"Zardo, G., A. Ciolfi, L. Vian, L.M. Starnes, M. Billi, S. Racanicchi, et al. 2012. Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression. Blood, The Journal of the American Society of Hematology 119 (17): 4034\u20134046.","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"3","key":"2125_CR152","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/ki.2013.469","volume":"85","author":"H Bao","year":"2014","unstructured":"Bao, H., H. Chen, X. Zhu, M. Zhang, G. Yao, Y. Yu, et al. 2014. MiR-223 downregulation promotes glomerular endothelial cell activation by upregulating importin \u03b14 and \u03b15 in IgA nephropathy. Kidney International 85 (3): 624\u2013635.","journal-title":"Kidney International"},{"issue":"9","key":"2125_CR153","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.7150\/ijbs.59876","volume":"17","author":"P Jiao","year":"2021","unstructured":"Jiao, P., X.-P. Wang, Z.-M. Luoreng, J. Yang, L. Jia, Y. Ma, et al. 2021. miR-223: An effective regulator of immune cell differentiation and inflammation. International Journal of Biological Sciences 17 (9): 2308.","journal-title":"International Journal of Biological Sciences"},{"key":"2125_CR154","doi-asserted-by":"publisher","first-page":"113923","DOI":"10.1016\/j.bbr.2022.113923","volume":"431","author":"L Liu","year":"2022","unstructured":"Liu, L., T. Zhou, T. Li, Z. Liang, and X. Luo. 2022. LncRNA DLX6-AS1 promotes microglial inflammatory response in Parkinson\u2019s disease by regulating the miR-223-3p\/NRP1 axis. Behavioural Brain Research 431: 113923.","journal-title":"Behavioural Brain Research"},{"key":"2125_CR155","doi-asserted-by":"crossref","unstructured":"He X, Jing Z, Cheng G.\u00a02014. MicroRNAs: new regulators of Toll-like receptor signalling pathways. BioMed research international. (1): 945169.","DOI":"10.1155\/2014\/945169"},{"issue":"12","key":"2125_CR156","doi-asserted-by":"publisher","first-page":"e2521-e","DOI":"10.1038\/cddis.2016.426","volume":"7","author":"Y-T Xiao","year":"2016","unstructured":"Xiao, Y.-T., J. Wang, W. Lu, Y. Cao, and W. Cai. 2016. Downregulated expression of microRNA-124 in pediatric intestinal failure patients modulates macrophages activation by inhibiting STAT3 and AChE. Cell Death & Disease 7 (12): e2521-e.","journal-title":"Cell Death & Disease"},{"issue":"5","key":"2125_CR157","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1002\/art.24475","volume":"60","author":"Y Nakamachi","year":"2009","unstructured":"Nakamachi, Y., S. Kawano, M. Takenokuchi, K. Nishimura, Y. Sakai, T. Chin, et al. 2009. MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis & Rheumatism 60 (5): 1294\u20131304.","journal-title":"Arthritis & Rheumatism"},{"issue":"11","key":"2125_CR158","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/cr.2013.116","volume":"23","author":"Y Sun","year":"2013","unstructured":"Sun, Y., Q. Li, H. Gui, D.-P. Xu, Y.-L. Yang, D.-F. Su, et al. 2013. MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines. Cell Research 23 (11): 1270\u20131283.","journal-title":"Cell Research"},{"key":"2125_CR159","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3389\/fimmu.2016.00406","volume":"7","author":"Z Qin","year":"2016","unstructured":"Qin, Z., P.-Y. Wang, D.-F. Su, and X. Liu. 2016. miRNA-124 in immune system and immune disorders. Frontiers in Immunology 7: 406.","journal-title":"Frontiers in Immunology"},{"issue":"12","key":"2125_CR160","doi-asserted-by":"publisher","first-page":"e81774","DOI":"10.1371\/journal.pone.0081774","volume":"8","author":"T Veremeyko","year":"2013","unstructured":"Veremeyko, T., S. Siddiqui, I. Sotnikov, A. Yung, and E.D. Ponomarev. 2013. IL-4\/IL-13-dependent and independent expression of miR-124 and its contribution to M2 phenotype of monocytic cells in normal conditions and during allergic inflammation. PLoS ONE 8 (12): e81774.","journal-title":"PLoS ONE"},{"issue":"4","key":"2125_CR161","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1053\/j.gastro.2013.07.001","volume":"145","author":"G Koukos","year":"2013","unstructured":"Koukos, G., C. Polytarchou, J.L. Kaplan, A. Morley-Fletcher, B. Gras-Miralles, E. Kokkotou, et al. 2013. MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. Gastroenterology 145 (4): 842\u201352. e2.","journal-title":"Gastroenterology"},{"issue":"10","key":"2125_CR162","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.molmed.2011.06.009","volume":"17","author":"H Soreq","year":"2011","unstructured":"Soreq, H., and Y. Wolf. 2011. NeurimmiRs: MicroRNAs in the neuroimmune interface. Trends in Molecular Medicine 17 (10): 548\u2013555.","journal-title":"Trends in Molecular Medicine"},{"issue":"1","key":"2125_CR163","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nm.2266","volume":"17","author":"ED Ponomarev","year":"2011","unstructured":"Ponomarev, E.D., T. Veremeyko, N. Barteneva, A.M. Krichevsky, and H.L. Weiner. 2011. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C\/EBP-\u03b1\u2013PU. 1 pathway. Nature Medicine 17 (1): 64\u201370.","journal-title":"Nature Medicine"},{"issue":"10","key":"2125_CR164","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/cns.12142","volume":"19","author":"Y Sun","year":"2013","unstructured":"Sun, Y., H. Gui, Q. Li, Z.M. Luo, M.J. Zheng, J.L. Duan, et al. 2013. MicroRNA-124 protects neurons against apoptosis in cerebral ischemic stroke. CNS Neuroscience & Therapeutics 19 (10): 813\u2013819.","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"8","key":"2125_CR165","doi-asserted-by":"publisher","first-page":"11455","DOI":"10.18632\/aging.202837","volume":"13","author":"H Cao","year":"2021","unstructured":"Cao, H., X. Han, Y. Jia, and B. Zhang. 2021. Inhibition of long non-coding RNA HOXA11-AS against neuroinflammation in Parkinson\u2019s disease model via targeting miR-124-3p mediated FSTL1\/NF-\u03baB axis. Aging 13 (8): 11455\u201311469.","journal-title":"Aging"},{"key":"2125_CR166","doi-asserted-by":"publisher","first-page":"118449","DOI":"10.1016\/j.ijpharm.2019.118449","volume":"567","author":"L Gan","year":"2019","unstructured":"Gan, L., Z. Li, Q. Lv, and W. Huang. 2019. Rabies virus glycoprotein (RVG29)-linked microRNA-124-loaded polymeric nanoparticles inhibit neuroinflammation in a Parkinson\u2019s disease model. International Journal of Pharmaceutics 567: 118449.","journal-title":"International Journal of Pharmaceutics"},{"issue":"9","key":"2125_CR167","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/acn3.51146","volume":"7","author":"S Ravanidis","year":"2020","unstructured":"Ravanidis, S., A. Bougea, N. Papagiannakis, C. Koros, A.M. Simitsi, I. Pachi, et al. 2020. Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients. Annals of Clinical and Translational Neurology 7 (9): 1594\u20131607.","journal-title":"Annals of Clinical and Translational Neurology"},{"key":"2125_CR168","doi-asserted-by":"publisher","first-page":"104515","DOI":"10.1016\/j.phrs.2019.104515","volume":"150","author":"E Angelopoulou","year":"2019","unstructured":"Angelopoulou, E., Y.N. Paudel, and C. Piperi. 2019. miR-124 and Parkinson\u2019s disease: A biomarker with therapeutic potential. Pharmacological Research 150: 104515.","journal-title":"Pharmacological Research"},{"issue":"2","key":"2125_CR169","first-page":"35","volume":"5","author":"JA Slota","year":"2019","unstructured":"Slota, J.A., and S.A. Booth. 2019. MicroRNAs in Neuroinflammation: Implications in Disease Pathogenesis, Biomarker Discovery and Therapeutic Applications. Noncoding RNA 5 (2): 35.","journal-title":"Noncoding RNA"},{"issue":"7","key":"2125_CR170","doi-asserted-by":"publisher","first-page":"8648","DOI":"10.1096\/fj.201900363R","volume":"33","author":"L Yao","year":"2019","unstructured":"Yao, L., Z. Zhu, J. Wu, Y. Zhang, H. Zhang, X. Sun, et al. 2019. MicroRNA-124 regulates the expression of p62\/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson\u2019s disease. The FASEB Journal 33 (7): 8648\u20138665.","journal-title":"The FASEB Journal"},{"issue":"18","key":"2125_CR171","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1177\/1535370217734492","volume":"242","author":"L Geng","year":"2017","unstructured":"Geng, L., W. Liu, and Y. Chen. 2017. miR-124-3p attenuates MPP(+)-induced neuronal injury by targeting STAT3 in SH-SY5Y cells. Experimental Biology and Medicine (Maywood, NJ) 242 (18): 1757\u20131764.","journal-title":"Experimental Biology and Medicine (Maywood, NJ)"},{"key":"2125_CR172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1053-4","volume":"15","author":"L Yao","year":"2018","unstructured":"Yao, L., Y. Ye, H. Mao, F. Lu, X. He, G. Lu, et al. 2018. MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson\u2019s disease. Journal of Neuroinflammation 15: 1\u201319.","journal-title":"Journal of Neuroinflammation"},{"key":"2125_CR173","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jconrel.2016.06.005","volume":"235","author":"C Saraiva","year":"2016","unstructured":"Saraiva, C., J. Paiva, T. Santos, L. Ferreira, and L. Bernardino. 2016. MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson\u2019s disease. Journal of Controlled Release\u202f: Official Journal of the Controlled Release Society 235: 291\u2013305.","journal-title":"Journal of Controlled Release : Official Journal of the Controlled Release Society"},{"key":"2125_CR174","doi-asserted-by":"publisher","first-page":"118449","DOI":"10.1016\/j.ijpharm.2019.118449","volume":"567","author":"L Gan","year":"2019","unstructured":"Gan, L., Z. Li, Q. Lv, and W. Huang. 2019. Rabies virus glycoprotein (RVG29)-linked microRNA-124-loaded polymeric nanoparticles inhibit neuroinflammation in a Parkinson\u2019s disease model. International Journal of Pharmaceutics 567: 118449.","journal-title":"International Journal of Pharmaceutics"},{"issue":"5824","key":"2125_CR175","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1126\/science.1141229","volume":"316","author":"TH Thai","year":"2007","unstructured":"Thai, T.H., D.P. Calado, S. Casola, K.M. Ansel, C. Xiao, Y. Xue, et al. 2007. Regulation of the germinal center response by microRNA-155. Science (New York, NY). 316 (5824): 604\u2013608.","journal-title":"Science (New York, NY)."},{"issue":"5","key":"2125_CR176","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1073\/pnas.0610731104","volume":"104","author":"RM O'Connell","year":"2007","unstructured":"O\u2019Connell, R.M., K.D. Taganov, M.P. Boldin, G. Cheng, and D. Baltimore. 2007. MicroRNA-155 is induced during the macrophage inflammatory response. Proceedings of the National Academy of Sciences 104 (5): 1604\u20131609.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"8","key":"2125_CR177","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.4049\/jimmunol.179.8.5082","volume":"179","author":"E Tili","year":"2007","unstructured":"Tili, E., J.J. Michaille, A. Cimino, S. Costinean, C.D. Dumitru, B. Adair, et al. 2007. Modulation of miR-155 and miR-125b levels following lipopolysaccharide\/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. Journal of immunology (Baltimore, Md\u202f: 1950) 179 (8): 5082\u20139.","journal-title":"Journal of immunology (Baltimore, Md : 1950)"},{"issue":"17","key":"2125_CR178","doi-asserted-by":"publisher","first-page":"7113","DOI":"10.1073\/pnas.0902636106","volume":"106","author":"RM O'Connell","year":"2009","unstructured":"O\u2019Connell, R.M., A.A. Chaudhuri, D.S. Rao, and D. Baltimore. 2009. Inositol phosphatase SHIP1 is a primary target of miR-155. Proceedings of the National Academy of Sciences. 106 (17): 7113\u20137118.","journal-title":"Proceedings of the National Academy of Sciences."},{"issue":"17","key":"2125_CR179","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1093\/nar\/gkp577","volume":"37","author":"J Worm","year":"2009","unstructured":"Worm, J., J. Stenvang, A. Petri, K.S. Frederiksen, S. Obad, J. Elm\u00e9n, et al. 2009. Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c\/ebp Beta and down-regulation of G-CSF. Nucleic Acids Research 37 (17): 5784\u20135792.","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"2125_CR180","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-2567.2011.03514.x","volume":"135","author":"AL Cardoso","year":"2012","unstructured":"Cardoso, A.L., J.R. Guedes, and L. Pereira de Almeida. 2012. miR-155 modulates microglia-mediated immune response by down-regulating SOCS-1 and promoting cytokine and nitric oxide production. Immunology 135 (1): 73\u201388.","journal-title":"Immunology"},{"issue":"1","key":"2125_CR181","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.immuni.2008.11.010","volume":"30","author":"LF Lu","year":"2009","unstructured":"Lu, L.F., T.H. Thai, D.P. Calado, A. Chaudhry, M. Kubo, K. Tanaka, et al. 2009. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30 (1): 80\u201391.","journal-title":"Immunity"},{"issue":"3","key":"2125_CR182","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1074\/jbc.M110.169367","volume":"286","author":"RT Martinez-Nunez","year":"2011","unstructured":"Martinez-Nunez, R.T., F. Louafi, and T. Sanchez-Elsner. 2011. The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1). The Journal of Biological Chemistry 286 (3): 1786\u20131794.","journal-title":"The Journal of Biological Chemistry"},{"issue":"7","key":"2125_CR183","doi-asserted-by":"publisher","first-page":"e0159724","DOI":"10.1371\/journal.pone.0159724","volume":"11","author":"KA Jablonski","year":"2016","unstructured":"Jablonski, K.A., A.D. Gaudet, S.A. Amici, P.G. Popovich, and M. Guerau-de-Arellano. 2016. Control of the Inflammatory Macrophage Transcriptional Signature by miR-155. PLoS ONE 11 (7): e0159724.","journal-title":"PLoS ONE"},{"issue":"32","key":"2125_CR184","doi-asserted-by":"publisher","first-page":"8516","DOI":"10.1523\/JNEUROSCI.0735-16.2016","volume":"36","author":"AD Gaudet","year":"2016","unstructured":"Gaudet, A.D., S. Mandrekar-Colucci, J.C. Hall, D.R. Sweet, P.J. Schmitt, X. Xu, et al. 2016. miR-155 Deletion in Mice Overcomes Neuron-Intrinsic and Neuron-Extrinsic Barriers to Spinal Cord Repair. The Journal of neuroscience\u202f: The Official Journal of the Society for Neuroscience 36 (32): 8516\u20138532.","journal-title":"The Journal of neuroscience : The Official Journal of the Society for Neuroscience"},{"issue":"3","key":"2125_CR185","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/1073858417721150","volume":"24","author":"AD Gaudet","year":"2017","unstructured":"Gaudet, A.D., L.K. Fonken, L.R. Watkins, R.J. Nelson, and P.G. Popovich. 2017. MicroRNAs: Roles in Regulating Neuroinflammation. The Neuroscientist 24 (3): 221\u2013245.","journal-title":"The Neuroscientist"},{"issue":"8","key":"2125_CR186","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1523\/JNEUROSCI.3900-15.2016","volume":"36","author":"AD Thome","year":"2016","unstructured":"Thome, A.D., A.S. Harms, L.A. Volpicelli-Daley, and D.G. Standaert. 2016. microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease. The Journal of neuroscience\u202f: The official journal of the Society for Neuroscience 36 (8): 2383\u20132390.","journal-title":"The Journal of neuroscience : The official journal of the Society for Neuroscience"},{"issue":"20","key":"2125_CR187","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1021\/acschemneuro.0c00375","volume":"11","author":"R Lv","year":"2020","unstructured":"Lv, R., L. Du, F. Zhou, X. Yuan, X. Liu, and L. Zhang. 2020. Rosmarinic acid alleviates inflammation, apoptosis, and oxidative stress through regulating miR-155-5p in a mice model of Parkinson\u2019s disease. ACS Chemical Neuroscience 11 (20): 3259\u20133266.","journal-title":"ACS Chemical Neuroscience"},{"key":"2125_CR188","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13148-016-0224-3","volume":"8","author":"V Carafa","year":"2016","unstructured":"Carafa, V., D. Rotili, M. Forgione, F. Cuomo, E. Serretiello, G.S. Hailu, et al. 2016. Sirtuin functions and modulation: From chemistry to the clinic. Clinical Epigenetics 8: 61.","journal-title":"Clinical Epigenetics"},{"issue":"7255","key":"2125_CR189","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nature08197","volume":"460","author":"T Finkel","year":"2009","unstructured":"Finkel, T., C.X. Deng, and R. Mostoslavsky. 2009. Recent progress in the biology and physiology of sirtuins. Nature 460 (7255): 587\u2013591.","journal-title":"Nature"},{"key":"2125_CR190","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cytogfr.2017.11.001","volume":"38","author":"KL Mendes","year":"2017","unstructured":"Mendes, K.L., D.F. Lelis, and S.H.S. Santos. 2017. Nuclear sirtuins and inflammatory signaling pathways. Cytokine & Growth Factor Reviews 38: 98\u2013105.","journal-title":"Cytokine & Growth Factor Reviews"},{"issue":"1","key":"2125_CR191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20070140","volume":"404","author":"S Michan","year":"2007","unstructured":"Michan, S., and D. Sinclair. 2007. Sirtuins in mammals: Insights into their biological function. Biochemical Journal 404 (1): 1\u201313.","journal-title":"Biochemical Journal"},{"issue":"9","key":"2125_CR192","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.tips.2012.05.007","volume":"33","author":"G Donmez","year":"2012","unstructured":"Donmez, G. 2012. The neurobiology of sirtuins and their role in neurodegeneration. Trends in Pharmacological Sciences 33 (9): 494\u2013501.","journal-title":"Trends in Pharmacological Sciences"},{"key":"2125_CR193","doi-asserted-by":"publisher","first-page":"172847","DOI":"10.1016\/j.ejphar.2019.172847","volume":"867","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., S. Anoopkumar-Dukie, D. Arora, and A.K. Davey. 2020. Review of the anti-inflammatory effect of SIRT1 and SIRT2 modulators on neurodegenerative diseases. European Journal of Pharmacology 867: 172847.","journal-title":"European Journal of Pharmacology"},{"key":"2125_CR194","doi-asserted-by":"crossref","unstructured":"Jiao, F. and Gong Z.\u00a02020.\u00a0 The beneficial roles of SIRT1 in neuroinflammation-related diseases. Oxidative medicine and cellular longevity. (1): 6782872.","DOI":"10.1155\/2020\/6782872"},{"issue":"4","key":"2125_CR195","doi-asserted-by":"publisher","first-page":"e61560","DOI":"10.1371\/journal.pone.0061560","volume":"8","author":"R Kumar","year":"2013","unstructured":"Kumar, R., P. Chaterjee, P.K. Sharma, A.K. Singh, A. Gupta, K. Gill, et al. 2013. Sirtuin1: A promising serum protein marker for early detection of Alzheimer\u2019s disease. PLoS ONE 8 (4): e61560.","journal-title":"PLoS ONE"},{"issue":"1","key":"2125_CR196","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/NEN.0b013e3181922348","volume":"68","author":"C Julien","year":"2009","unstructured":"Julien, C., C. Tremblay, V. Emond, M. Lebbadi, N. Salem Jr., D.A. Bennett, et al. 2009. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. Journal of Neuropathology & Experimental Neurology 68 (1): 48\u201358.","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"key":"2125_CR197","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s10072-020-04711-z","volume":"42","author":"Y Zhu","year":"2021","unstructured":"Zhu, Y., X. Zhu, Y. Zhou, and D. Zhang. 2021. Reduced serum SIRT1 levels in patients with Parkinson\u2019s disease: A cross-sectional study in China. Neurological Sciences 42: 1835\u20131841.","journal-title":"Neurological Sciences"},{"issue":"2","key":"2125_CR198","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1523\/JNEUROSCI.2939-14.2015","volume":"35","author":"S-H Cho","year":"2015","unstructured":"Cho, S.-H., J.A. Chen, F. Sayed, M.E. Ward, F. Gao, T.A. Nguyen, et al. 2015. SIRT1 deficiency in microglia contributes to cognitive decline in aging and neurodegeneration via epigenetic regulation of IL-1\u03b2. Journal of Neuroscience 35 (2): 807\u2013818.","journal-title":"Journal of Neuroscience"},{"issue":"5","key":"2125_CR199","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1128\/MCB.00705-08","volume":"29","author":"T Yoshizaki","year":"2009","unstructured":"Yoshizaki, T., J.C. Milne, T. Imamura, S. Schenk, N. Sonoda, J.L. Babendure, et al. 2009. SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Molecular and Cellular Biology 29 (5): 1363\u20131374.","journal-title":"Molecular and Cellular Biology"},{"issue":"4","key":"2125_CR200","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.cmet.2009.02.006","volume":"9","author":"A Purushotham","year":"2009","unstructured":"Purushotham, A., T.T. Schug, Q. Xu, S. Surapureddi, X. Guo, and X. Li. 2009. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metabolism 9 (4): 327\u2013338.","journal-title":"Cell Metabolism"},{"issue":"5682","key":"2125_CR201","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1126\/science.1099196","volume":"305","author":"HY Cohen","year":"2004","unstructured":"Cohen, H.Y., C. Miller, K.J. Bitterman, N.R. Wall, B. Hekking, B. Kessler, et al. 2004. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science (New York, NY) 305 (5682): 390\u2013392.","journal-title":"Science (New York, NY)"},{"key":"2125_CR202","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neulet.2019.02.038","volume":"701","author":"Z Wang","year":"2019","unstructured":"Wang, Z., L. Sun, K. Jia, H. Wang, and X. Wang. 2019. miR-9-5p modulates the progression of Parkinson\u2019s disease by targeting SIRT1. Neuroscience Letters 701: 226\u2013233.","journal-title":"Neuroscience Letters"},{"key":"2125_CR203","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neulet.2018.03.037","volume":"675","author":"L Geng","year":"2018","unstructured":"Geng, L., T. Zhang, W. Liu, and Y. Chen. 2018. miR-494-3p modulates the progression of in vitro and in vivo Parkinson\u2019s disease models by targeting SIRT3. Neuroscience Letters 675: 23\u201330.","journal-title":"Neuroscience Letters"},{"issue":"1","key":"2125_CR204","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1166\/jbt.2020.2219","volume":"10","author":"Y Guo","year":"2020","unstructured":"Guo, Y., and X. Hua. 2020. MicroRNA-181a-5p down-regulation presents neuroprotective effect in 1-methyl-4-phenylpyridinium-induced Parkinson\u2019s disease: An in vitro study. Journal of Biomaterials and Tissue Engineering 10 (1): 63\u201370.","journal-title":"Journal of Biomaterials and Tissue Engineering"},{"key":"2125_CR205","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.expneurol.2018.01.016","volume":"302","author":"M Ren","year":"2018","unstructured":"Ren, M., Y. Guo, X. Wei, S. Yan, Y. Qin, X. Zhang, et al. 2018. TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson\u2019s disease. Experimental Neurology 302: 205\u2013213.","journal-title":"Experimental Neurology"},{"issue":"43","key":"2125_CR206","doi-asserted-by":"publisher","first-page":"11524","DOI":"10.1073\/pnas.1710311114","volume":"114","author":"CEG Leyns","year":"2017","unstructured":"Leyns, C.E.G., J.D. Ulrich, M.B. Finn, F.R. Stewart, L.J. Koscal, J. Remolina Serrano, et al. 2017. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy. Proceedings of the National Academy of Sciences of the United States of America 114 (43): 11524\u201311529.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"2125_CR207","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang, Y., T.K. Ulland, J.D. Ulrich, W. Song, J.A. Tzaferis, J.T. Hole, et al. 2016. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. The Journal of Experimental Medicine 213 (5): 667\u2013675.","journal-title":"The Journal of Experimental Medicine"},{"key":"2125_CR208","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-015-0040-9","volume":"10","author":"MM Painter","year":"2015","unstructured":"Painter, M.M., Y. Atagi, C.C. Liu, R. Rademakers, H. Xu, J.D. Fryer, et al. 2015. TREM2 in CNS homeostasis and neurodegenerative disease. Molecular Neurodegeneration 10: 43.","journal-title":"Molecular Neurodegeneration"},{"issue":"6","key":"2125_CR209","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang, Y., M. Cella, K. Mallinson, J.D. Ulrich, K.L. Young, M.L. Robinette, et al. 2015. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell 160 (6): 1061\u20131071.","journal-title":"Cell"},{"issue":"3","key":"2125_CR210","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00401-015-1388-1","volume":"129","author":"C Cantoni","year":"2015","unstructured":"Cantoni, C., B. Bollman, D. Licastro, M. Xie, R. Mikesell, R. Schmidt, et al. 2015. TREM2 regulates microglial cell activation in response to demyelination in vivo. Acta Neuropathologica 129 (3): 429\u2013447.","journal-title":"Acta Neuropathologica"},{"issue":"7","key":"2125_CR211","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1523\/JNEUROSCI.2459-16.2017","volume":"37","author":"H Zheng","year":"2017","unstructured":"Zheng, H., L. Jia, C.C. Liu, Z. Rong, L. Zhong, L. Yang, et al. 2017. TREM2 Promotes Microglial Survival by Activating Wnt\/\u03b2-Catenin Pathway. The Journal of neuroscience\u202f: The Official Journal of the Society for Neuroscience. 37 (7): 1772\u20131784.","journal-title":"The Journal of neuroscience : The Official Journal of the Society for Neuroscience."},{"issue":"4","key":"2125_CR212","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.bbrc.2018.03.226","volume":"499","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., S. Feng, K. Nie, Y. Li, Y. Gao, R. Gan, et al. 2018. TREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson\u2019s disease. Biochemical and Biophysical Research Communications 499 (4): 797\u2013802.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"2125_CR213","doi-asserted-by":"crossref","unstructured":"Huang, P. Zhang, Z. Zhang, P. Feng, J. Xie, J. Zheng, Y. et al.\u00a02024. TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson\u2019s Disease Mice and LPS-Induced BV2 Cells. Molecular Neurobiology. 61 (5): 2590\u20132605.","DOI":"10.1007\/s12035-023-03713-0"},{"issue":"3","key":"2125_CR214","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/jnc.15299","volume":"157","author":"Q Lv","year":"2021","unstructured":"Lv, Q., Z. Zhong, B. Hu, S. Yan, Y. Yan, J. Zhang, et al. 2021. MicroRNA-3473b regulates the expression of TREM2\/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson disease. Journal of Neurochemistry 157 (3): 599\u2013610.","journal-title":"Journal of Neurochemistry"},{"issue":"4","key":"2125_CR215","doi-asserted-by":"publisher","first-page":"Ns20220063","DOI":"10.1042\/NS20220063","volume":"7","author":"N Dzamko","year":"2023","unstructured":"Dzamko, N. 2023. Cytokine activity in Parkinson\u2019s disease. Neuronal Signaling 7 (4): Ns20220063.","journal-title":"Neuronal Signaling"},{"key":"2125_CR216","doi-asserted-by":"publisher","first-page":"5193036","DOI":"10.1155\/2020\/5193036","volume":"2020","author":"AM Gorabi","year":"2020","unstructured":"Gorabi, A.M., N. Kiaie, T. Sathyapalan, K. Al-Rasadi, T. Jamialahmadi, and A. Sahebkar. 2020. The Role of MicroRNAs in Regulating Cytokines and Growth Factors in Coronary Artery Disease: The Ins and Outs. Journal of Immunology Research 2020: 5193036.","journal-title":"Journal of Immunology Research"},{"key":"2125_CR217","doi-asserted-by":"crossref","unstructured":"Gong, X. Huang, M. Chen, L.\u00a02022. Mechanism of miR-132\u20133p promoting neuroinflammation and dopaminergic neurodegeneration in Parkinson\u2019s Disease. Eneuro.\u00a09 (1).","DOI":"10.1523\/ENEURO.0393-21.2021"},{"issue":"18","key":"2125_CR218","doi-asserted-by":"publisher","first-page":"22390","DOI":"10.18632\/aging.203545","volume":"13","author":"X Bai","year":"2021","unstructured":"Bai, X., X. Zhang, R. Fang, J. Wang, Y. Ma, Z. Liu, et al. 2021. Deficiency of miR-29b2\/c leads to accelerated aging and neuroprotection in MPTP-induced Parkinson\u2019s disease mice. Aging 13 (18): 22390\u201322411.","journal-title":"Aging"},{"issue":"9","key":"2125_CR219","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/iub.2344","volume":"72","author":"S Zhou","year":"2020","unstructured":"Zhou, S., D. Zhang, J. Guo, Z. Chen, Y. Chen, and J. Zhang. 2020. Long non-coding RNA NORAD functions as a microRNA-204-5p sponge to repress the progression of Parkinson\u2019s disease in vitro by increasing the solute carrier family 5 member 3 expression. IUBMB Life 72 (9): 2045\u20132055.","journal-title":"IUBMB Life"},{"issue":"10","key":"2125_CR220","first-page":"6619","volume":"11","author":"M Wang","year":"2019","unstructured":"Wang, M., H. Sun, Y. Yao, X. Tang, and B. Wu. 2019. MicroRNA-217\/138-5p downregulation inhibits inflammatory response, oxidative stress and the induction of neuronal apoptosis in MPP(+)-induced SH-SY5Y cells. American Journal of Translational Research 11 (10): 6619\u20136631.","journal-title":"American Journal of Translational Research"},{"issue":"39","key":"2125_CR221","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1039\/C2CC36540E","volume":"49","author":"PN Brown","year":"2013","unstructured":"Brown, P.N., and H. Yin. 2013. PNA-based microRNA inhibitors elicit anti-inflammatory effects in microglia cells. Chemical Communications (Cambridge, England) 49 (39): 4415\u20134417.","journal-title":"Chemical Communications (Cambridge, England)"},{"issue":"10","key":"2125_CR222","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/j.1440-1681.2009.05245.x","volume":"36","author":"BF Yang","year":"2009","unstructured":"Yang, B.F., Y.J. Lu, and Z.G. Wang. 2009. MicroRNAs and apoptosis: Implications in the molecular therapy of human disease. Clinical and Experimental Pharmacology and Physiology 36 (10): 951\u2013960.","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"2125_CR223","doi-asserted-by":"publisher","first-page":"111800","DOI":"10.1016\/j.mad.2023.111800","volume":"211","author":"KP Tryphena","year":"2023","unstructured":"Tryphena, K.P., G. Singh, N. Jain, P. Famta, S. Srivastava, S.B. Singh, et al. 2023. Integration of miRNA\u2019s theranostic potential with nanotechnology: Promises and challenges for Parkinson\u2019s disease therapeutics. Mechanisms of Ageing and Development. 211: 111800.","journal-title":"Mechanisms of Ageing and Development."},{"key":"2125_CR224","doi-asserted-by":"publisher","first-page":"104876","DOI":"10.1016\/j.jddst.2023.104876","volume":"87","author":"G Singh","year":"2023","unstructured":"Singh, G., A. Sikder, V. Phatale, S. Srivastava, S.B. Singh, and D.K. Khatri. 2023. Therapeutic potential of GDNF in neuroinflammation: Targeted delivery approaches for precision treatment in neurological diseases. Journal of Drug Delivery Science and Technology. 87: 104876.","journal-title":"Journal of Drug Delivery Science and Technology."},{"issue":"2","key":"2125_CR225","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s13577-017-0187-5","volume":"31","author":"D Li","year":"2018","unstructured":"Li, D., H. Yang, J. Ma, S. Luo, S. Chen, and Q. Gu. 2018. MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson\u2019s disease by targeting Nlrp3. Human Cell 31 (2): 106\u2013115.","journal-title":"Human Cell"},{"issue":"6","key":"2125_CR226","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/gtc.12764","volume":"25","author":"R Wang","year":"2020","unstructured":"Wang, R., Q. Li, Y. He, Y. Yang, Q. Ma, and C. Li. 2020. miR-29c-3p inhibits microglial NLRP3 inflammasome activation by targeting NFAT5 in Parkinson\u2019s disease. Genes to Cells 25 (6): 364\u2013374.","journal-title":"Genes to Cells"},{"key":"2125_CR227","doi-asserted-by":"publisher","first-page":"175302","DOI":"10.1016\/j.ejphar.2022.175302","volume":"934","author":"Y-L Yang","year":"2022","unstructured":"Yang, Y.-L., T.-K. Lin, and Y.-H. Huang. 2022. MiR-29a inhibits MPP + - Induced cell death and inflammation in Parkinson\u2019s disease model in vitro by potential targeting of MAVS. European Journal of Pharmacology 934: 175302.","journal-title":"European Journal of Pharmacology"},{"key":"2125_CR228","doi-asserted-by":"publisher","first-page":"106614","DOI":"10.1016\/j.intimp.2020.106614","volume":"85","author":"W Xu","year":"2020","unstructured":"Xu, W., L. Zhang, Y. Geng, Y. Liu, and N. Zhang. 2020. Long noncoding RNA GAS5 promotes microglial inflammatory response in Parkinson\u2019s disease by regulating NLRP3 pathway through sponging miR-223-3p. International Immunopharmacology. 85: 106614.","journal-title":"International Immunopharmacology."},{"key":"2125_CR229","doi-asserted-by":"publisher","first-page":"113923","DOI":"10.1016\/j.bbr.2022.113923","volume":"431","author":"L Liu","year":"2022","unstructured":"Liu, L., T. Zhou, T. Li, Z. Liang, and X. Luo. 2022. LncRNA DLX6-AS1 promotes microglial inflammatory response in Parkinson\u2019s disease by regulating the miR-223\u20133p\/NRP1 axis. Behavioural Brain Research. 431: 113923.","journal-title":"Behavioural Brain Research."},{"key":"2125_CR230","doi-asserted-by":"crossref","unstructured":"Oliveira, S. R., Dion\u00edsio P. A., Gaspar, M. M., Correia Guedes L. Coelho, M. Rosa, M. M. et al.\u00a02021. miR-335 targets LRRK2 and mitigates inflammation in parkinson\u2019s disease. Frontiers in cell and Developmental Biology. 9:661461.","DOI":"10.3389\/fcell.2021.661461"},{"issue":"3","key":"2125_CR231","doi-asserted-by":"publisher","first-page":"315","DOI":"10.17219\/acem\/154658","volume":"32","author":"Y-J Zhang","year":"2023","unstructured":"Zhang, Y.-J., W.-K. Zhu, F.-Y. Qi, and F.-Y. Che. 2023. CircHIPK3 promotes neuroinflammation through regulation of the miR-124-3p\/STAT3\/NLRP3 signaling pathway in Parkinson\u2019s disease. Advances in Clinical and Experimental Medicine 32 (3): 315\u2013329.","journal-title":"Advances in Clinical and Experimental Medicine"},{"issue":"1","key":"2125_CR232","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12974-018-1053-4","volume":"15","author":"L Yao","year":"2018","unstructured":"Yao, L., Y. Ye, H. Mao, F. Lu, X. He, G. Lu, et al. 2018. MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson\u2019s disease. Journal of Neuroinflammation 15 (1): 13.","journal-title":"Journal of Neuroinflammation"},{"issue":"4","key":"2125_CR233","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.bbrc.2019.08.140","volume":"519","author":"J Zhang","year":"2019","unstructured":"Zhang, J., Z. Dongwei, Z. Zhang, Q. Xinhui, B. Kunwang, L. Guohui, et al. 2019. miR-let-7a suppresses \u03b1-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson\u2019s disease. Biochemical and Biophysical Research Communications 519 (4): 740\u2013746.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"2125_CR234","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2147\/NDT.S286778","volume":"17","author":"X Xiao","year":"2021","unstructured":"Xiao, X., Z. Tan, M. Jia, X. Zhou, K. Wu, Y. Ding, et al. 2021. Long Noncoding RNA SNHG1 Knockdown Ameliorates Apoptosis, Oxidative Stress and Inflammation in Models of Parkinson\u2019s Disease by Inhibiting the miR-125b-5p\/MAPK1 Axis. Neuropsychiatric Disease and Treatment 17: 1153\u201363.","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"1","key":"2125_CR235","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1080\/21655979.2021.2015527","volume":"13","author":"Y Lang","year":"2022","unstructured":"Lang, Y., H. Zhang, H. Yu, Y. Li, X. Liu, and M. Li. 2022. Long non-coding RNA myocardial infarction-associated transcript promotes 1-Methyl-4-phenylpyridinium ion-induced neuronal inflammation and oxidative stress in Parkinson\u2019s disease through regulating microRNA-221-3p\/ transforming growth factor \/nuclear factor E2-related factor 2 axis. Bioengineered 13 (1): 930\u2013940.","journal-title":"Bioengineered"},{"issue":"2","key":"2125_CR236","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.1080\/21655979.2022.2033409","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang, J., Y. Yang, C. Zhou, R. Zhu, X. Xiao, B. Zhou, et al. 2022. LncRNA miR-17-92a-1 cluster host gene (MIR17HG) promotes neuronal damage and microglial activation by targeting the microRNA-153-3p\/alpha-synuclein axis in Parkinson\u2019s disease. Bioengineered 13 (2): 4493\u20134516.","journal-title":"Bioengineered"},{"key":"2125_CR237","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jocn.2019.04.004","volume":"65","author":"R Zeng","year":"2019","unstructured":"Zeng, R., D.-X. Luo, H.-P. Li, Q.-S. Zhang, S.-S. Lei, and J.-H. Chen. 2019. MicroRNA-135b alleviates MPP+-mediated Parkinson\u2019s disease in in vitro model through suppressing FoxO1-induced NLRP3 inflammasome and pyroptosis. Journal of Clinical Neuroscience 65: 125\u2013133.","journal-title":"Journal of Clinical Neuroscience"},{"key":"2125_CR238","doi-asserted-by":"publisher","first-page":"5806146","DOI":"10.1155\/2017\/5806146","volume":"2017","author":"J Zhang","year":"2017","unstructured":"Zhang, J., W. Liu, Y. Wang, S. Zhao, and N. Chang. 2017. miR-135b Plays a Neuroprotective Role by Targeting GSK3\u03b2 in MPP(+)-Intoxicated SH-SY5Y Cells. Disease Markers 2017: 5806146.","journal-title":"Disease Markers"},{"issue":"8","key":"2125_CR239","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41419-018-0821-5","volume":"9","author":"Y Ye","year":"2018","unstructured":"Ye, Y., X. He, F. Lu, H. Mao, Z. Zhu, L. Yao, et al. 2018. A lincRNA-p21\/miR-181 family feedback loop regulates microglial activation during systemic LPS- and MPTP- induced neuroinflammation. Cell Death & Disease 9 (8): 803.","journal-title":"Cell Death & Disease"},{"key":"2125_CR240","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s11064-020-03157-1","volume":"46","author":"T Liu","year":"2021","unstructured":"Liu, T., Y. Zhang, W. Liu, and J. Zhao. 2021. LncRNA NEAT1 regulates the development of Parkinson\u2019s disease by targeting AXIN1 via sponging miR-212-3p. Neurochemical Research 46: 230\u2013240.","journal-title":"Neurochemical Research"},{"issue":"8","key":"2125_CR241","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1523\/JNEUROSCI.3900-15.2016","volume":"36","author":"AD Thome","year":"2016","unstructured":"Thome, A.D., A.S. Harms, L.A. Volpicelli-Daley, and D.G. Standaert. 2016. microRNA-155 regulates alpha-synuclein-induced inflammatory responses in models of Parkinson disease. Journal of Neuroscience 36 (8): 2383\u20132390.","journal-title":"Journal of Neuroscience"},{"issue":"2","key":"2125_CR242","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s13760-023-02388-7","volume":"124","author":"X Lin","year":"2023","unstructured":"Lin, X., T. Tao, X. He, L. Mao, L. Pan, and L. Chen. 2023. LncRNA MEG8 ameliorates Parkinson\u2019s disease neuro-inflammation through miR-485\u20133p\/FBXO45 axis. Acta Neurologica Belgica 124 (2): 549\u2013557.","journal-title":"Acta Neurologica Belgica"},{"issue":"2","key":"2125_CR243","doi-asserted-by":"publisher","first-page":"12867","DOI":"10.1080\/21655979.2021.2005928","volume":"12","author":"L Yan","year":"2021","unstructured":"Yan, L., L. Li, and J. Lei. 2021. Long noncoding RNA small nucleolar RNA host gene 12\/microRNA-138-5p\/nuclear factor I\/B regulates neuronal apoptosis, inflammatory response, and oxidative stress in Parkinson\u2019s disease. Bioengineered 12 (2): 12867\u201312879.","journal-title":"Bioengineered"},{"key":"2125_CR244","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O'Brien","year":"2018","unstructured":"O\u2019Brien, J., H. Hayder, Y. Zayed, and C. Peng. 2018. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Frontiers in Endocrinology 9: 402.","journal-title":"Frontiers in Endocrinology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02125-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-024-02125-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02125-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T10:04:02Z","timestamp":1751969042000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-024-02125-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":244,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["2125"],"URL":"https:\/\/doi.org\/10.1007\/s10753-024-02125-z","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"3 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"COMPETING OF INTEREST"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}